USE OF S-ADENOSYL-L-MENTHIONINE IN THE TREATMENT OF INTRAHEPATIC CHOLESTASIS DETERMINED BY TOTAL PARENTERAL NUTRITION

摘要

The invention relates to the use of S-adenosyl-L-methionine (SAMe) in the form of pharmaceutically acceptable salts in the preparation of injectable pharmaceutical compositions for the prevention and symptomatic treatment of intrahepatic cholestasis determined by total parenteral nutrition.